A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Na, Xi ^a   Martin, Alan J ^b   Sethi, Saurabh ^a   Kyne, Lorraine ^b   Garey, Kevin W ^c   Flores, Sarah W ^a   Hu, Mary ^a   Shah, Dhara N ^c   Shields, Kelsey ^a   Leffler, Daniel A ^a   Kelly, Ciarán P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECISION MAKING; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PEPTOCLOSTRIDIUM DIFFICILE; PREDICTION; PROSPECTIVE STUDY; RESUSCITATION; SCORING SYSTEM; VALIDATION PROCESS; CLINICAL TRIAL; CLOSTRIDIUM INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY;

CLOSTRIDIUM DIFFICILE;

AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84929308128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123405     Document Type: Article

References (33)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-55. doi: 10.1086/651706 PMID: 20307191
2. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med. 2008; 359(18):1932-40. doi: 10.1056/NEJMra0707500 PMID: 18971494
3. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010; 31(10):1030-7. doi: 10.1086/656245 PMID: 20695799
4. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. 2006; 12(3):409-15. PMID: 16704777
5. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23):2442-9. PMID: 16322602
6. McDonald LC, Killgore GE, Thompson A, Owens RC Jr., Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353(23):2433-41. PMID: 16322603
7. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008; 46(4):497-504. doi: 10.1086/526530 PMID: 18197759
8. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002; 34(3):346-53. PMID: 11774082
9. O'Brien JA, Lahue BJ, Caro M J Jaime, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007; 28(11):1219-27. PMID: 17926270
10. Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009; 301(9):954-62. doi: 10.1001/jama.2009.171 PMID: 19190304
11. Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010; 50(12):e77-81. doi: 10.1086/653012 PMID: 20450417
12. Arora V, Kachroo S, Ghantoji SS, Dupont HL, Garey KW. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. J Hosp Infect. 2011; 79(1):23-6. doi: 10.1016/j.jhin.2011.04.027 PMID: 21700363
13. Kelly CP, Kyne L. The host immune response to Clostridium difficile. J Med Microbiol. 2011; 60(Pt 8):1070-9.
14. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007; 45(3):302-7. PMID: 17599306
15. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009; 15(12):1067-79. doi: 10.1111/j.1469-0691.2009.03099.x PMID: 19929973
16. Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009; 136 (4):1206-14. doi: 10.1053/j.gastro.2008.12.038 PMID: 19162027
17. Hu MY, Maroo S, Kyne L, Cloud J, Tummala S, Katchar K, et al. A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. Clin Gastroenterol Hepatol. 2008; 6(12):1354-60. doi: 10.1016/j.cgh.2008.06.024 PMID: 19081526
18. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium Difficile Strain NAP-1 Is Not Associated With Severe Disease In a Nonepidemic Setting. Clin Gastroenterol Hepatol. 2009.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. PMID: 3558716
20. Horn SD, Sharkey PD, Bertram DA. Measuring severity of illness: homogeneous case mix groups. Med Care. 1983; 21(1):14-30. PMID: 6403781
21. McDonald L, Coignard B, Dubberke E, Song X, Horan T, Kutty PK, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007; 28(2):140-5. PMID: 17265394
22. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007; 13(9):1417. doi: 10.3201/eid1309.061116 PMID: 18252127
23. Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012; 12(4):281-9. doi: 10.1016/S1473-3099(11) 70374-7 PMID: 22321770
24. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011; 364(5):422-31. doi: 10.1056/NEJMoa0910812 PMID: 21288078
25. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010; 362(3):197. doi: 10.1056/NEJMoa0907635 PMID: 20089970
26. Abou Chakra CN, Pepin J, Valiquette L. Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS One. 2012; 7(1):e30258. doi: 10.1371/journal.pone.0030258 PMID: 22291926
27. Bhangu S, Bhangu A, Nightingale P, Michael A. Mortality and risk stratification in patients with Clostridium difficile?associated diarrhoea. Colorectal Dis. 2010; 12(3):241-6. doi: 10.1111/j.1463-1318.2009.01832.x PMID: 19508548
28. Lungulescu O, Cao W, Gatskevich E, Tlhabano L, Stratidis J. CSI: a severity index for Clostridium difficile infection at the time of admission. J Hosp Infect. 2011; 79(2):151-4. doi: 10.1016/j.jhin.2011.04.017 PMID: 21849220
29. Zilberberg MD, Shorr AF, Micek ST, Doherty JA, Kollef MH. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med. 2009; 37(9):2583-9. doi: 10.1097/CCM.0b013e3181ab8388 PMID: 19623053
30. Laupacis A, Sekar N. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997; 277(6):488-94. PMID: 9020274
31. May S, Rosedale R. Prescriptive clinical prediction rules in back pain research: a systematic review. Journal of Manual & Manipulative Therapy. 2009; 17(1):36-45.
32. Pepin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol. 2007; 102(12):2781-8. PMID: 17900327
33. Burns K, Skally M, Solomon K, Scott L, McDermott S, O'Flanagan D, et al. Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009. Infect Control Hosp Epidemiol. 2010; 31(10):1085-7. doi: 10.1086/656376 PMID: 20731596